Key facts
| Price (PPV) | 46.70 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | molsidomine |
| Class | Cardiac therapy |
| ATC code | C01DX12 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boîte de 30 |
| Nature | Médicament |
| Hospital price | 29.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement préventif de la crise angineuse sous toutes ses formes. Les comprimés de CORVASAL ne sont pas adaptés au traitement de la crise d'angor.
Find an open pharmacy
On-call pharmacies near you
About Corvasal 2 mg
Corvasal 2 mg belongs to the cardiac therapy therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Corvasal 2 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Corvasal 2 mg
Answers to common questions from Moroccan patients about this drug.